Current Scheduling Status
None
Year(s) and type of review / ECDD meetings
Drug Class
Recommendation (from TRS)
ECDD Technical summary
This substance, commonly known as DMA, is a racemic mixture that has a pharmacological profile similar to that of mescaline at low doses and of amphetamine at high doses. It apparently produces hallucinations in man. Drug discrimination studies indicate that its effects are similar to those observed with hallucinogens. 2,5-Dimethoxyamphetamine has no known medical use, but it is used in the photographic industry. There are a number of reports of illicittrafficking in the substance. On the basis of the data outlined above, it was the consensus of the Expert Committee that 2,5-dimethoxyamphetamine met the criteria in article 2, paragraph 4, for control under the Convention on Psychotropic Substances. Since this substance has no known clinical use, the Expert Committee recommended that it be placed in Schedule I of the Convention.
This substance, commonly known as DMA, is a racemic mixture that has a pharmacological profile similar to that of mescaline at low doses and of amphetamine at high doses. It apparently produces hallucinations in man. Drug discrimination studies indicate that its effects are similar to those observed with hallucinogens. 2,5-Dimethoxyamphetamine has no known medical use, but it is used in the photographic industry. There are a number of reports of illicittrafficking in the substance. On the basis of the data outlined above, it was the consensus of the Expert Committee that 2,5-dimethoxyamphetamine met the criteria in article 2, paragraph 4, for control under the Convention on Psychotropic Substances. Since this substance has no known clinical use, the Expert Committee recommended that it be placed in Schedule I of the Convention.
ECDD Recommendation
Inclusion in Schedule I of the 1971 Convention on Psychotropic Substances
Link to full TRS
who_trs_729.pdf1.29 MB